These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 19763880)

  • 1. DNA methyltransferase expression differs with proliferation in childhood acute lymphoblastic leukemia.
    Sayin DB; Kürekçi E; Karabulut HG; Ezer U; Bökesoy I
    Mol Biol Rep; 2010 Jun; 37(5):2471-6. PubMed ID: 19763880
    [No Abstract]   [Full Text] [Related]  

  • 2. Increased midkine gene expression in childhood B-precursor acute lymphoblastic leukemia.
    Hidaka H; Yagasaki H; Takahashi Y; Hama A; Nishio N; Tanaka M; Yoshida N; Villalobos IB; Wang Y; Xu Y; Horibe K; Chen S; Kadomatsu K; Kojima S
    Leuk Res; 2007 Aug; 31(8):1045-51. PubMed ID: 17267033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curcumin-Mediated Reversal of p15 Gene Promoter Methylation: Implication in Anti-Neoplastic Action against Acute Lymphoid Leukaemia Cell Line.
    Sharma V; Jha AK; Kumar A; Bhatnagar A; Narayan G; Kaur J
    Folia Biol (Praha); 2015; 61(2):81-9. PubMed ID: 26333125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. hTERT promoter methylation and telomere length in childhood acute lymphoblastic leukemia: associations with immunophenotype and cytogenetic subgroup.
    Borssén M; Cullman I; Norén-Nyström U; Sundström C; Porwit A; Forestier E; Roos G
    Exp Hematol; 2011 Dec; 39(12):1144-51. PubMed ID: 21914494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WT1 protein expression in childhood acute leukemia.
    Kerst G; Bergold N; Gieseke F; Coustan-Smith E; Lang P; Kalinova M; Handgretinger R; Trka J; Müller I
    Am J Hematol; 2008 May; 83(5):382-6. PubMed ID: 18161786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Messenger RNA expression of resistance factors and their correlation to the proliferative activity in childhood acute lymphoblastic leukemia.
    Stammler G; Sauerbrey A; Volm M
    Cancer Lett; 1995 Feb; 89(1):129-35. PubMed ID: 7882295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of Livin, an antiapoptotic protein, is an independent favorable prognostic factor in childhood acute lymphoblastic leukemia.
    Choi J; Hwang YK; Sung KW; Lee SH; Yoo KH; Jung HL; Koo HH; Kim HJ; Kang HJ; Shin HY; Ahn HS
    Blood; 2007 Jan; 109(2):471-7. PubMed ID: 16990595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of novel markers for monitoring minimal residual disease in acute lymphoblastic leukemia.
    Chen JS; Coustan-Smith E; Suzuki T; Neale GA; Mihara K; Pui CH; Campana D
    Blood; 2001 Apr; 97(7):2115-20. PubMed ID: 11264179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and molecular genetic characterization of wild-type MLL infant acute lymphoblastic leukemia identifies few recurrent abnormalities.
    van der Linden MH; Boer JM; Schneider P; Willekes M; Seslija L; De Lorenzo P; Valsecchi MG; Cazzaniga G; Biondi A; den Boer ML; Pieters R; Stam RW
    Haematologica; 2016 Mar; 101(3):e95-8. PubMed ID: 26681762
    [No Abstract]   [Full Text] [Related]  

  • 10. Cellular expression of antiapoptotic BCL-2 oncoprotein in newly diagnosed childhood acute lymphoblastic leukemia: a Children's Cancer Group Study.
    Uckun FM; Yang Z; Sather H; Steinherz P; Nachman J; Bostrom B; Crotty L; Sarquis M; Ek O; Zeren T; Tubergen D; Reaman G; Gaynon P
    Blood; 1997 May; 89(10):3769-77. PubMed ID: 9160683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical relevance of BCL-2 overexpression in childhood acute lymphoblastic leukemia.
    Coustan-Smith E; Kitanaka A; Pui CH; McNinch L; Evans WE; Raimondi SC; Behm FG; Aricò M; Campana D
    Blood; 1996 Feb; 87(3):1140-6. PubMed ID: 8562940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNMT3A mutations and prognostic significance in childhood acute lymphoblastic leukemia.
    Li W; Gao C; Cui L; Liu S; Zhao X; Zhang R; Wu M; Zheng H; Deng G; Li Z; Zhang Q
    Leuk Lymphoma; 2015 Apr; 56(4):1066-71. PubMed ID: 25242092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SLC2A5 overexpression in childhood philadelphia chromosome-positive acute lymphoblastic leukaemia.
    Zhao P; Huang J; Zhang D; Zhang D; Wang F; Qu Y; Guo T; Qin Y; Wei J; Niu T; Zheng Y
    Br J Haematol; 2018 Oct; 183(2):242-250. PubMed ID: 30272826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ex vivo resistance in childhood acute lymphoblastic leukemia: Correlations between BCRP, MRP1, MRP4 and MRP5 ABC transporter expression and intracellular methotrexate polyglutamate accumulation.
    Jaramillo AC; Cloos J; Lemos C; Stam RW; Kaspers GJL; Jansen G; Peters GJ
    Leuk Res; 2019 Apr; 79():45-51. PubMed ID: 30849662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of constitutive activation of Janus kinases and signal transduction and activation of transcription factors in Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Kanwar VS; Witthuhn B; Campana D; Ihle JN
    Blood; 1996 Jun; 87(11):4911-2. PubMed ID: 8639867
    [No Abstract]   [Full Text] [Related]  

  • 16. Hinokitiol induces DNA demethylation via DNMT1 and UHRF1 inhibition in colon cancer cells.
    Seo JS; Choi YH; Moon JW; Kim HS; Park SH
    BMC Cell Biol; 2017 Feb; 18(1):14. PubMed ID: 28241740
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Hormann FM; Hoogkamer AQ; Beverloo HB; Boeree A; Dingjan I; Wattel MM; Stam RW; Escherich G; Pieters R; den Boer ML; Boer JM
    Haematologica; 2019 Oct; 104(10):e455-e459. PubMed ID: 30872366
    [No Abstract]   [Full Text] [Related]  

  • 18. The association of aberrant folylpolyglutamate synthetase splicing with ex vivo methotrexate resistance and clinical outcome in childhood acute lymphoblastic leukemia.
    Wojtuszkiewicz A; Assaraf YG; Hoekstra M; Sciarrillo R; Jansen G; Peters GJ; Pieters R; Sonneveld E; Escherich G; Kaspers GJ; Cloos J
    Haematologica; 2016 Jul; 101(7):e291-4. PubMed ID: 27036162
    [No Abstract]   [Full Text] [Related]  

  • 19. Combined Casein Kinase II inhibition and epigenetic modulation in acute B-lymphoblastic leukemia.
    Richter A; Roolf C; Hamed M; Gladbach YS; Sender S; Konkolefski C; Knübel G; Sekora A; Fuellen G; Vollmar B; Murua Escobar H; Junghanss C
    BMC Cancer; 2019 Mar; 19(1):202. PubMed ID: 30841886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effect of curcumin on MDR1 gene expression in patient leukemic cells.
    Anuchapreeda S; Thanarattanakorn P; Sittipreechacharn S; Tima S; Chanarat P; Limtrakul P
    Arch Pharm Res; 2006 Oct; 29(10):866-73. PubMed ID: 17121181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.